Replies to post #807 on Revive Therapeutics Ltd (RVVTF)

[starkd748]

Actually retraced 61% so far today from yesterday's high....

[Nosnibor]

I agree with you. Buying way more today given this temporary dip in PPS.
The only fear-mongering poster on here is “starkd” and given what is at stake here (a potential cure for saving a lot of lives), Revive is a rare example of a company that we ALL need to support and get behind. With that support Revive will be better positioned to succeed and human lives will be saved.
Publicly spreading fear without an actual ‘crystal ball’, or undermining this stock without proven evidence is a crime against humanity if you think about it.
@Starkd, you are clocked.

[ReikoBlack]

Fress, what's the latest word from your friend who is a "Pharma analyst at Goldman Sachs"?

You need to go back to chart school you have no idea whats coming RVVTF Phase 3 drug with very low side affects to treat large patient populations of Covid-19.Gap filled perfectly at .2003 Wave 5 Fib RVVTF price target $10.00 by end of summer. My friend is a Pharma analyst at Goldman Sachs. He says if Approval on RVVTF Bucillamine comes for Covid-19. At hits current market cap. The price valuations will between $20.00-$30.00


$RVVTF